Stock INVO INVO BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages INVO Bioscience, Inc.

Equities

INVO

US44984F4019

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
0.86 USD -4.09% Intraday chart for INVO Bioscience, Inc. -3.37% -36.30%
May. 15 INVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 18 Top Premarket Decliners MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
INVO Reports Record First Quarter 2024 Financial Results
INVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK
Top Premarket Decliners
Sector Update: Health Care Stocks Retreating Late Afternoon
Top Midday Gainers
Traders Digest Earnings After Rate-Driven Losses, US Equity Futures Rebound Slightly
Top Premarket Gainers
INVO Reports Fourth Quarter and Full Year 2023 Financial Results
INVO Bioscience : Reports Fourth Quarter and Full Year 2023 Financial Results - Form 8-K
INVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
INVO Bioscience, Inc. announced that it has received $0.5 million in funding from FirstFire Capital Management LLC
INVO Bioscience, Inc. announced that it expects to receive $0.5 million in funding from FirstFire Capital Management LLC
INVO Bioscience : Private Placement - Form 8-K
Certain Options of INVO Bioscience, Inc. are subject to a Lock-Up Agreement Ending on 9-FEB-2024.
Certain Warrants of INVO Bioscience, Inc. are subject to a Lock-Up Agreement Ending on 9-FEB-2024.
Certain Common Stock of INVO Bioscience, Inc. are subject to a Lock-Up Agreement Ending on 9-FEB-2024.
INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors
INVO Bioscience, Inc. announced that it expects to receive $5 million in funding from NAYA Biosciences Inc.
INVO Bioscience : Submission of Matters to a Vote of Security Holders - Form 8-K
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INVO Stock
  4. News INVO Bioscience, Inc.
  5. Other languages